 Connection
Nicholas Cost to Combined Modality Therapy
This is a "connection" page, showing publications Nicholas Cost has written about Combined Modality Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.362 |
|
|
|
-
Halstead NV, Mikkilineni N, Cost CR, Cost NG. Aggressive Multimodality Therapy for a Urachal Rhabdomyosarcoma. Urology. 2022 07; 165:e20-e24.
Score: 0.162
-
Saltzman AF, Cost NG. Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma. Curr Urol Rep. 2018 Feb 22; 19(1):11.
Score: 0.122
-
Saltzman AF, Cost NG, Romao RLP. Wilms Tumor. Urol Clin North Am. 2023 Aug; 50(3):455-464.
Score: 0.044
-
Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, Emamekhoo H, Feldman DR, Geynisman DM, Hancock SL, LaGrange C, Levine EG, Longo T, Lowrance W, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Saylor P, Sircar K, Smith DC, Tzou K, Vaena D, Vaughn D, Yamoah K, Yamzon J, Johnson-Chilla A, Keller J, Pluchino LA. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 12; 17(12):1529-1554.
Score: 0.034
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|